Literature DB >> 26975784

Nesfatin-1 increases intracellular calcium concentration by protein kinase C activation in cultured rat dorsal root ganglion neurons.

Mete Ozcan1, Zeynep Betul Gok2, Emine Kacar2, Ihsan Serhatlioglu3, Haluk Kelestimur2.   

Abstract

Nesfatin-1 is a recently identified anorexigenic hypothalamic polypeptide derived from the posttranslational processing of nucleobindin 2 (NUCB2). Several studies have indicated that this neuropeptide may be participated in somatosensory and visceral transmission including pain signals in addition to energy metabolism. The aim of this study was to explore the possible role of nesfatin-1 in the transmission of peripheral neural signals by investigating the effects of nesfatin-1 on intracellular free calcium levels ([Ca(2+)]i) in cultured neonatal rat dorsal root ganglion (DRG) neurons. The effects of nesfatin-1 on [Ca(2+)]i in DRG neurons were investigated by using an in vitro calcium imaging system. DRG neurons were grown in primary culture following enzymatic and mechanical dissociation of ganglia from 1-or 2-day-old neonatal Wistar rats. Using the fura-2-based calcium imaging technique, the effects of nesfatin-1 on [Ca(2+)]i and role of the protein kinase C (PKC)-mediated pathway in nesfatin-1 effect were assessed. Nesfatin-1 elevated [Ca(2+)]i in cultured DRG neurons. The response was prevented by pretreating the cells with pertussis toxin. The protein kinase C inhibitor chelerythrine chloride suppressed nesfatin-1-induced rise in [Ca(2+)]i. The result shows that nesfatin-1 interacts with a G protein-coupled receptor, leading to an increase of [Ca(2+)]i, which is linked to protein kinase C activation in cultured rat DRG neurons.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Calcium signaling; G protein; Nesfatin; Pain; Protein kinase-C; Sensory neurons

Mesh:

Substances:

Year:  2016        PMID: 26975784     DOI: 10.1016/j.neulet.2016.03.018

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  8 in total

Review 1.  Neuroprotective Effects of Brain-Gut Peptides: A Potential Therapy for Parkinson's Disease.

Authors:  Dong Dong; Junxia Xie; Jun Wang
Journal:  Neurosci Bull       Date:  2019-07-08       Impact factor: 5.203

2.  Expression and function of nesfatin-1 are altered by stage of the estrous cycle.

Authors:  Alicia T Pate; Abigayle L Schnell; Teresa A Ennis; Willis K Samson; Gina L C Yosten
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-05-29       Impact factor: 3.619

3.  SERUM NESFATIN-1 LEVEL IN HEALTHY SUBJECTS WITH WEIGHT-RELATED ABNORMALITIES AND NEWLY DIAGNOSED PATIENTS WITH TYPE 2 DIABETES MELLITUS; A CASE-CONTROL STUDY.

Authors:  S Mirakhor Samani; H Ghasemi; K Rezaei Bookani; B Shokouhi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jan-Mar       Impact factor: 0.877

Review 4.  Gut-Brain Neuroendocrine Signaling Under Conditions of Stress-Focus on Food Intake-Regulatory Mediators.

Authors:  Andreas Stengel; Yvette Taché
Journal:  Front Endocrinol (Lausanne)       Date:  2018-08-28       Impact factor: 5.555

Review 5.  Calcium Signaling Pathways: Key Pathways in the Regulation of Obesity.

Authors:  Ziguo Song; Yu Wang; Fei Zhang; Fangyao Yao; Chao Sun
Journal:  Int J Mol Sci       Date:  2019-06-05       Impact factor: 5.923

Review 6.  Minireview: Peripheral Nesfatin-1 in Regulation of the Gut Activity-15 Years since the Discovery.

Authors:  Katarzyna Kras; Siemowit Muszyński; Ewa Tomaszewska; Marcin B Arciszewski
Journal:  Animals (Basel)       Date:  2022-01-01       Impact factor: 2.752

7.  Selected neuropeptide genes show genetic differentiation between Africans and non-Africans.

Authors:  Kah Yee Tai; KokSheik Wong; Farhang Aghakhanian; Ishwar S Parhar; Jasbir Dhaliwal; Qasim Ayub
Journal:  BMC Genet       Date:  2020-03-14       Impact factor: 2.797

8.  Nesfatin-1 Receptor: Distribution, Signaling and Increasing Evidence for a G Protein-Coupled Receptor - A Systematic Review.

Authors:  Sophia Kristina Rupp; Ellen Wölk; Andreas Stengel
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-10       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.